Evidence map›Paper›PMID 27284035›Full record

ReviewBiochemical Society transactions2016

Synthetic promoter design for new microbial chassis.

James Gilman, John Love

Abstract readReview
In one paragraph

Review in Biochemical Society transactions, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. A universal approach to gene expression engineering.Synthetic biology (Oxford, England) · 2022
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Characterization of Context-Dependent Effects on Synthetic Promoters.Frontiers in bioengineering and biotechnology · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Development ofBiotechnology for biofuels · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

James GilmanBiosciences, College of Life and Environmental Sciences, The University of Exeter, Stocker Road, Exeter EX4 4QD, U.K.
John LoveBiosciences, College of Life and Environmental Sciences, The University of Exeter, Stocker Road, Exeter EX4 4QD, U.K. J.Love@Exeter.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The judicious choice of promoter to drive gene expression remains one of the most important considerations for synthetic biology applications. Constitutive promoter sequences isolated from nature are often used in laboratory settings or small-scale commercial production streams, but unconventional microbial chassis for new synthetic biology applications require well-characterized, robust and orthogonal promoters. This review provides an overview of the opportunities and challenges for synthetic promoter discovery and design, including molecular methodologies, such as saturation mutagenesis of flanking regions and mutagenesis by error-prone PCR, as well as the less familiar use of computational and statistical analyses for de novo promoter design.

Indexed as

Promoter Regions, GeneticComputational BiologyGene ExpressionGenetic EngineeringSynthetic Biologyartificial neural networkspartial least squares modellingpromotersynthetic biologysystems biology

Identifiers

PMID27284035
PMCPMC4900742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.